206 related articles for article (PubMed ID: 28878133)
21. Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens.
Ibusuki M; Fu P; Yamamoto S; Fujiwara S; Yamamoto Y; Honda Y; Iyama K; Iwase H
Breast Cancer; 2013 Apr; 20(2):159-66. PubMed ID: 22139726
[TBL] [Abstract][Full Text] [Related]
22. Whole exome sequencing of rare aggressive breast cancer histologies.
Dieci MV; Smutná V; Scott V; Yin G; Xu R; Vielh P; Mathieu MC; Vicier C; Laporte M; Drusch F; Guarneri V; Conte P; Delaloge S; Lacroix L; Fromigué O; André F; Lefebvre C
Breast Cancer Res Treat; 2016 Feb; 156(1):21-32. PubMed ID: 26907767
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
24. Effect of Hydrochloric Acid Decalcification on Expression Pattern of Prognostic Markers in Invasive Breast Carcinomas.
Maclary SC; Mohanty SK; Bose S; Chung F; Balzer BL
Appl Immunohistochem Mol Morphol; 2017 Feb; 25(2):144-149. PubMed ID: 27028239
[TBL] [Abstract][Full Text] [Related]
25. Mining the Archives: A Cross-Platform Analysis of Gene Expression Profiles in Archival Formalin-Fixed Paraffin-Embedded Tissues.
Webster AF; Zumbo P; Fostel J; Gandara J; Hester SD; Recio L; Williams A; Wood CE; Yauk CL; Mason CE
Toxicol Sci; 2015 Dec; 148(2):460-72. PubMed ID: 26361796
[TBL] [Abstract][Full Text] [Related]
26. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
[TBL] [Abstract][Full Text] [Related]
27. Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination.
Pegolo E; Machin P; Riosa F; Bassini A; Deroma L; Di Loreto C
Cancer Cytopathol; 2012 Jun; 120(3):196-205. PubMed ID: 22298467
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient.
Johnson J; Bessette DC; Saunus JM; Smart CE; Song S; Johnston RL; Cocciardi S; Rozali EN; Johnstone CN; Vargas AC; Kazakoff SH; BioBank VC; Khanna KK; Lakhani SR; Chenevix-Trench G; Simpson PT; Nones K; Waddell N; Al-Ejeh F
Breast Cancer Res Treat; 2018 Jul; 170(1):179-188. PubMed ID: 29468485
[TBL] [Abstract][Full Text] [Related]
29. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging.
Abdel-Rahman O
Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329
[TBL] [Abstract][Full Text] [Related]
30. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq.
Li P; Conley A; Zhang H; Kim HL
BMC Genomics; 2014 Dec; 15(1):1087. PubMed ID: 25495041
[TBL] [Abstract][Full Text] [Related]
31. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
32. Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.
Park IH; Kwon Y; Ro JY; Lee KS; Ro J
Breast Cancer Res Treat; 2010 Aug; 123(1):125-8. PubMed ID: 19916047
[TBL] [Abstract][Full Text] [Related]
33. Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
Trinkaus M; Ooi WS; Amir E; Popovic S; Kalina M; Kahn H; Singh G; Gainford MC; Clemons M
Oncol Rep; 2009 May; 21(5):1153-9. PubMed ID: 19360288
[TBL] [Abstract][Full Text] [Related]
34. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
35. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer.
Siegel MB; He X; Hoadley KA; Hoyle A; Pearce JB; Garrett AL; Kumar S; Moylan VJ; Brady CM; Van Swearingen AE; Marron D; Gupta GP; Thorne LB; Kieran N; Livasy C; Mardis ER; Parker JS; Chen M; Anders CK; Carey LA; Perou CM
J Clin Invest; 2018 Apr; 128(4):1371-1383. PubMed ID: 29480819
[TBL] [Abstract][Full Text] [Related]
36. BRCA Mutation-Related and Claudin-Low Breast Cancer: Blood Relatives or Stepsisters.
Madaras L; Balint N; Gyorffy B; Tokes AM; Barshack I; Yosepovich A; Friedman E; Paluch-Shimon S; Zippel D; Baghy K; Timar J; Kovalszky I; Kulka J; Szasz AM
Pathobiology; 2016; 83(1):1-12. PubMed ID: 26566278
[TBL] [Abstract][Full Text] [Related]
37. Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
Cosphiadi I; Atmakusumah TD; Siregar NC; Muthalib A; Harahap A; Mansyur M
Clin Breast Cancer; 2018 Oct; 18(5):e1117-e1122. PubMed ID: 29609951
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer.
Brunn Rasmussen B; Kamby C
Pathol Res Pract; 1989 Dec; 185(6):856-9. PubMed ID: 2616369
[TBL] [Abstract][Full Text] [Related]
39. HER-2/neu genotype of breast cancer may change in bone metastasis.
Lôrincz T; Tóth J; Badalian G; Tímár J; Szendrôi M
Pathol Oncol Res; 2006; 12(3):149-52. PubMed ID: 16998594
[TBL] [Abstract][Full Text] [Related]
40. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis.
Bouizar Z; Spyratos F; De vernejoul MC
J Bone Miner Res; 1999 Mar; 14(3):406-14. PubMed ID: 10027905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
